Home »
Academic Articles »
C »
Encapsulation of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in liposomes prepared by thin film hydration and their transfer to mesenchymal stem cells and cord blood hematopoietic stem cells
Encapsulation of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in liposomes prepared by thin film hydration and their transfer to mesenchymal stem cells and cord blood hematopoietic stem cells
Sławomir Lewicki
(Department of Regenerative Medicine and Cell Biology, Military Institute of Hygiene and Epidemiology, Warsaw, Poland)
Monika Leśniak
(Department of Regenerative Medicine and Cell Biology, Military Institute of Hygiene and Epidemiology, Warsaw, Poland)
Agnieszka Sobolewska-Ruta
(Bioengineering Department, The Institute of Biotechnology and Antibiotics, Warsaw, Poland)
Aneta Lewicka
(Laboratory of Food and Nutrition Hygiene, Military Institute of Hygiene and Epidemiology, Warsaw, Poland)
Marta Grodzik
(Division of Nanobiotechnology, Faculty of Animal Sciences, Warsaw University of Life Sciences, Warsaw, Poland)
Eugeniusz K. Machaj
(Polish Stem Cell Bank, Warsaw, Poland)
Marek Saracyn
(Department of Endocrinology and Isotope Therapy, Military Institute of Medicine, Warsaw, Poland)
Jacek Z. Kubiak
(Department of Regenerative Medicine and Cell Biology, Military Institute of Hygiene and Epidemiology, Warsaw, Poland)
Zygmunt Pojda
(Department of Regenerative Medicine, Maria Skłodowska-Curie Institute-Oncology Center, Warsaw, Poland)
Journal: Archives of Medical Science
•
• Termedia Publishing House
• ISSN: 1734-1922
Abstract
Introduction
Cytokines are important immune modulator factors controlling homeostasis of the body and are involved in tissue regeneration after wound healing. The encapsulation of cytokines in liposomes has many advantages potentially useful for their transfer to the cells. Liposomes protect cytokines from neutralization, improving their pharmacokinetics or biologic activity in vivo. They are targeted to specific cell types and may delay the release of cytokines, allowing their sustained paracrine delivery. Their physicochemical characteristics such as size, shape, charge, and stability are important parameters improving bio-distribution and prolonged pharmacokinetics of encapsulated cytokines.
Material and methods
We developed an efficient protocol for the encapsulation of two types of cytokines, granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF), in liposomes that can be stored long term in the active state.
Results
This method allows for the encapsulation of 12–13% of the total amount of cytokines and 50% of encapsulated cytokines are entrapped in liposomes of more than ≤ 600 nm in diameter. We show that in the studied cell lines the liposome-encapsulated cytokines do not affect cell morphology, proliferation or mortality.
Conclusions
The G-CSF or GM-CSF can be delivered to the cells in working concentrations through the encapsulation in the liposomes. Before the clinical application, the efficiency of these liposomes should be confirmed by an in vivo study.
Sławomir Lewicki, Monika Leśniak, Agnieszka Sobolewska-Ruta, et al. (2020). "Encapsulation of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in liposomes prepared by thin film hydration and their transfer to mesenchymal stem cells and cord blood hematopoietic stem cells". Archives of Medical Science. https://doi.org/10.5114/aoms.2020.94527